Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100578370> ?p ?o ?g. }
- W2100578370 endingPage "e72637" @default.
- W2100578370 startingPage "e72637" @default.
- W2100578370 abstract "Distinctive genotypic and phenotypic features of ovarian cancer via epithelial-mesenchymal transition (EMT) have been correlated with drug resistance and disease recurrence. We investigated whether therapeutic reversal of EMT could re-sensitize ovarian cancer cells (OCCs) to existing chemotherapy. We report that epimorphin, a morphogenic protein, has pivotal control over mesenchymal versus epithelial cell lineage decision of the putative OCCs. Exposure to epimorphin induced morphological changes reminiscent of mesenchymal-to-epithelial transition (MET), but in a dose dependent manner, i.e., at 10 µg/mL of epimorphin cells obtain a more mesenchymal-like morphology while at 20 µg/mL of epimorphin cells display an epithelial morphology. The latter changes were accompanied by suppression of mesenchymal markers, such as vimentin (∼8-fold↓, p<0.02), Twist1 (∼7-fold↓, p<0.03), dystroglycan (∼4-fold↓, p<0.01) and palladin (∼3-fold↓, p<0.01). Conversely, significant elevations of KLF4 (∼28-fold↑, p<0.002), β-catenin (∼6-fold↑, p<0.004), EpCAM (∼6-fold↑, p<0.0002) and occludin (∼15-fold↑, p<0.004) mRNAs as part of the commitment to the epithelial cell lineage were detected in response to 20 µg/mL of exogenous epimorphin. Changes in occludin mRNA levels were accompanied by a parallel, albeit weaker expression at the protein level (∼5-fold↑, p<0.001). Likewise, acquisition of epithelial-like properties, including mucin1, CK19, and β-catenin gene expression, was also obtained following epimorphin treatment. Further, MMP3 production was found to be reduced whereas laminin secretion was strongly amplified upon epimorphin-induced MET. These results suggest there is a dosage window for actions of epimorphin on cellular differentiation, wherein it can either suppress or enhance epithelial differentiation of OCCs. Importantly, induction of epithelial-like phenotypes by epimorphin led to an enhanced sensitivity to carboplatin. Overall, we demonstrate that epimorphin can revert OCCs away from their mesenchymal phenotype and toward an epithelial phenotype, thereby enhancing their sensitivity to a front-line chemotherapeutic agent." @default.
- W2100578370 created "2016-06-24" @default.
- W2100578370 creator A5003443127 @default.
- W2100578370 creator A5004192215 @default.
- W2100578370 creator A5033625395 @default.
- W2100578370 creator A5055575157 @default.
- W2100578370 creator A5090244006 @default.
- W2100578370 date "2013-09-09" @default.
- W2100578370 modified "2023-10-16" @default.
- W2100578370 title "Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum" @default.
- W2100578370 cites W1498970130 @default.
- W2100578370 cites W1964081206 @default.
- W2100578370 cites W1966051785 @default.
- W2100578370 cites W1982147906 @default.
- W2100578370 cites W2005040818 @default.
- W2100578370 cites W2017905687 @default.
- W2100578370 cites W2018414855 @default.
- W2100578370 cites W2018778742 @default.
- W2100578370 cites W2019237060 @default.
- W2100578370 cites W2023223175 @default.
- W2100578370 cites W2029565396 @default.
- W2100578370 cites W2035015033 @default.
- W2100578370 cites W2044224053 @default.
- W2100578370 cites W2047475076 @default.
- W2100578370 cites W2066060929 @default.
- W2100578370 cites W2068036342 @default.
- W2100578370 cites W2070755882 @default.
- W2100578370 cites W2072046699 @default.
- W2100578370 cites W2074978112 @default.
- W2100578370 cites W2080297105 @default.
- W2100578370 cites W2085776836 @default.
- W2100578370 cites W2093817605 @default.
- W2100578370 cites W2098974513 @default.
- W2100578370 cites W2102003692 @default.
- W2100578370 cites W2108244474 @default.
- W2100578370 cites W2117427620 @default.
- W2100578370 cites W2125120607 @default.
- W2100578370 cites W2156111332 @default.
- W2100578370 cites W2158877558 @default.
- W2100578370 cites W2163569157 @default.
- W2100578370 cites W2170556339 @default.
- W2100578370 cites W2328386272 @default.
- W2100578370 cites W4238254576 @default.
- W2100578370 doi "https://doi.org/10.1371/journal.pone.0072637" @default.
- W2100578370 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3767807" @default.
- W2100578370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24039787" @default.
- W2100578370 hasPublicationYear "2013" @default.
- W2100578370 type Work @default.
- W2100578370 sameAs 2100578370 @default.
- W2100578370 citedByCount "19" @default.
- W2100578370 countsByYear W21005783702014 @default.
- W2100578370 countsByYear W21005783702015 @default.
- W2100578370 countsByYear W21005783702016 @default.
- W2100578370 countsByYear W21005783702017 @default.
- W2100578370 countsByYear W21005783702018 @default.
- W2100578370 countsByYear W21005783702020 @default.
- W2100578370 countsByYear W21005783702021 @default.
- W2100578370 crossrefType "journal-article" @default.
- W2100578370 hasAuthorship W2100578370A5003443127 @default.
- W2100578370 hasAuthorship W2100578370A5004192215 @default.
- W2100578370 hasAuthorship W2100578370A5033625395 @default.
- W2100578370 hasAuthorship W2100578370A5055575157 @default.
- W2100578370 hasAuthorship W2100578370A5090244006 @default.
- W2100578370 hasBestOaLocation W21005783701 @default.
- W2100578370 hasConcept C104317684 @default.
- W2100578370 hasConcept C127561419 @default.
- W2100578370 hasConcept C147447768 @default.
- W2100578370 hasConcept C150194340 @default.
- W2100578370 hasConcept C153911025 @default.
- W2100578370 hasConcept C177779419 @default.
- W2100578370 hasConcept C198826908 @default.
- W2100578370 hasConcept C203014093 @default.
- W2100578370 hasConcept C204232928 @default.
- W2100578370 hasConcept C2775962179 @default.
- W2100578370 hasConcept C2777933648 @default.
- W2100578370 hasConcept C2778265714 @default.
- W2100578370 hasConcept C2779018089 @default.
- W2100578370 hasConcept C502942594 @default.
- W2100578370 hasConcept C55493867 @default.
- W2100578370 hasConcept C76419328 @default.
- W2100578370 hasConcept C86339819 @default.
- W2100578370 hasConcept C86803240 @default.
- W2100578370 hasConcept C95444343 @default.
- W2100578370 hasConceptScore W2100578370C104317684 @default.
- W2100578370 hasConceptScore W2100578370C127561419 @default.
- W2100578370 hasConceptScore W2100578370C147447768 @default.
- W2100578370 hasConceptScore W2100578370C150194340 @default.
- W2100578370 hasConceptScore W2100578370C153911025 @default.
- W2100578370 hasConceptScore W2100578370C177779419 @default.
- W2100578370 hasConceptScore W2100578370C198826908 @default.
- W2100578370 hasConceptScore W2100578370C203014093 @default.
- W2100578370 hasConceptScore W2100578370C204232928 @default.
- W2100578370 hasConceptScore W2100578370C2775962179 @default.
- W2100578370 hasConceptScore W2100578370C2777933648 @default.
- W2100578370 hasConceptScore W2100578370C2778265714 @default.
- W2100578370 hasConceptScore W2100578370C2779018089 @default.
- W2100578370 hasConceptScore W2100578370C502942594 @default.
- W2100578370 hasConceptScore W2100578370C55493867 @default.